CA9 Antikörper (AA 251-350) (AbBy Fluor® 350)
Kurzübersicht für CA9 Antikörper (AA 251-350) (AbBy Fluor® 350) (ABIN885950)
Target
Alle CA9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 251-350
-
Verwendungszweck
- CA9 Polyclonal Antibody, AbBy Fluor-350 Conjugated
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Homologie
- Dog,Cow,Pig,Horse
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human Carbonic Anhydrase 9
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- CA9 (Carbonic Anhydrase IX (CA9))
-
Andere Bezeichnung
- Carbonic Anhydrase 9
-
Hintergrund
-
Synonyms: MN, CAIX, Carbonic anhydrase 9, Carbonate dehydratase IX, Carbonic anhydrase IX, CA-IX, Membrane antigen MN, P54/58N, Renal cell carcinoma-associated antigen G250, RCC-associated antigen G250, pMW1, CA9, G250
Background: Reversible hydration of carbon dioxide. Participates in pH regulation. May be involved in the control of cell proliferation and transformation. Appears to be a novel specific biomarker for a cervical neoplasia.
-
Gen-ID
- 768
-
UniProt
- Q16790
Target
-